Johan F Vansteenkiste Selected Research

technetium Tc 99m BTAP-annexin-V

2/2004

Positron emission tomography in the management of non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan F Vansteenkiste Research Topics

Disease

17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2005
17	Neoplasms (Cancer) 01/2022 - 07/2002
8	Lung Neoplasms (Lung Cancer) 11/2018 - 02/2004
5	Disease Progression 01/2022 - 11/2018
4	Exanthema (Rash) 01/2022 - 03/2011
3	Anemia 03/2011 - 04/2008
2	Diarrhea 01/2022 - 03/2011
2	Nausea 11/2018 - 03/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 05/2008
2	Neutropenia 10/2015 - 01/2012
1	Colitis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Dermatitis 01/2022
1	Hyperphosphatemia 01/2020
1	Malignant Mesothelioma 01/2020
1	Edema (Dropsy) 11/2018
1	Adenocarcinoma 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2012
1	Asthenia 03/2011
1	Fatigue 03/2011
1	Vomiting 03/2011
1	Hypertension (High Blood Pressure) 03/2011
1	Solitary Pulmonary Nodule 02/2004
1	Hypoxia (Hypoxemia) 02/2004

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2005
3	durvalumabIBA 01/2022 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 06/2021 - 01/2016
3	HematinicsIBA 05/2008 - 01/2006
2	LigandsIBA 01/2022 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 06/2021 - 11/2018
2	Amylases FDA Link 01/2020 - 11/2018
2	Pemetrexed (MTA)FDA Link 01/2020 - 03/2011
2	ceritinibIBA 01/2020 - 10/2014
2	Lipase (Acid Lipase)FDA Link 01/2020 - 11/2018
2	Pharmaceutical PreparationsIBA 11/2018 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2016
2	Hemoglobins (Hemoglobin)IBA 05/2008 - 04/2008
2	Glucose (Dextrose)FDA LinkGeneric 02/2004 - 07/2002
1	osimertinibIBA 06/2021
1	TabletsIBA 06/2021
1	B7-H1 AntigenIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	TransferasesIBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	NivolumabIBA 01/2020
1	FP-1039IBA 01/2020
1	Gefitinib (Iressa)FDA Link 11/2018
1	capmatinibIBA 11/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2016
1	Chimeric Antigen ReceptorsIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2015
1	NVP-BKM120IBA 09/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015
1	CrizotinibIBA 10/2014
1	Anaplastic Lymphoma KinaseIBA 10/2014
1	Gemcitabine FDA Link 01/2012
1	vandetanib (ZD6474)IBA 03/2011
1	Etoposide (VP 16)FDA LinkGeneric 05/2008
1	PlatinumIBA 05/2008
1	IronIBA 04/2008
1	Erythropoietin FDA Link 01/2006
1	Darbepoetin alfa (Aranesp)FDA Link 01/2006
1	Biological ProductsIBA 11/2004
1	technetium Tc 99m BTAP-annexin-VIBA 02/2004
1	Carrier Proteins (Binding Protein)IBA 02/2004
1	fluoromisonidazoleIBA 02/2004
1	EnzymesIBA 02/2004

Therapy/Procedure

9	Therapeutics 06/2021 - 02/2004
9	Drug Therapy (Chemotherapy) 01/2016 - 02/2004
3	Chemoradiotherapy 01/2022 - 01/2021
2	Immunotherapy 01/2018 - 01/2018
2	Adjuvant Chemotherapy 10/2015 - 02/2005
2	Radiotherapy 01/2006 - 02/2004
1	Precision Medicine 03/2016
1	Aftercare (After-Treatment) 05/2008